Newsroom

نيويورك--(BUSINESS WIRE)--أعلنت Workiva Inc. (المدرجة في بورصة نيويورك بالرمز: WK)، الرائدة في توفير منصة جاهزة للتدقيق لترسيخ الثقة والشفافية والمساءلة، اليوم نتائج استبيانها المرجعي للمسؤولين التنفيذيين للنصف الأول من عام 2026.على الرغم من أن 84% من المسؤولين التنفيذيين المشاركين في الاستبيان يبدون ثقة، ولو جزئيًا، في دقة مخرجات الذكاء الاصطناعي دون مراجعة بشرية، أفاد واحد من كل أربعة منهم (26%) بأن عمليات التدقيق الداخلية رصدت أخطاء ناجمة عن الذكاء الاصطناعي وصلت إلى جمهور خارجي أو إلى أعضاء...

LIVINGSTON, N.J.--(BUSINESS WIRE)--CoreWeave Reports Strong Second Quarter 2026 Results...

WASHINGTON--(BUSINESS WIRE)--CAVA Group, Inc. (NYSE: CAVA) (“CAVA Group” or the “Company”), the category-defining Mediterranean fast-casual restaurant brand that brings heart, health, and humanity to food, today announced financial results for its fiscal second quarter ended July 12, 2026. “Our second quarter results underscore the continued strength of our category-defining brand and the resonance of our value proposition with today’s consumer,” said Brett Schulman, Co-Founder and CEO. “Same r...

GAINESVILLE, Va.--(BUSINESS WIRE)--MightyMeals today announced it has been ranked No. 2,348 on the 2026 Inc. 5000 list, the annual ranking of the fastest-growing private companies in America. The list is the most prestigious ranking of the nation’s most successful independent and entrepreneurial businesses, recognizing companies that have achieved remarkable growth while driving innovation, creating jobs, and shaping the future of the economy. Past honorees include companies such as Microsoft,...

CENTENNIAL, Colo.--(BUSINESS WIRE)--National CineMedia, Inc. (NASDAQ: NCMI) (the “Company” or “NCM”), the managing member of National CineMedia, LLC (NCM LLC), the operator of the largest cinema advertising platform in the U.S., today announced its consolidated results for the fiscal second quarter ended July 2, 2026. “NCM delivered another quarter of meaningful growth alongside the strong domestic box office,” said Tom Lesinski, Chief Executive Officer of National CineMedia, Inc. “We navigated...

NEW YORK--(BUSINESS WIRE)--Please replace the release dated July 30, 2026 with the following corrected version due to multiple revisions. The updated release reads: ELLIS EMERGES FROM STEALTH WITH MORE THAN $10 MILLION TO BUILD THE AI-NATIVE OPERATING FOUNDATION FOR PRIVATE CREDIT Launched by Cadre founder Ryan Williams, Ellis gives private credit managers a reconciled, source-verifiable data foundation and purpose-built AI agents to help them scale. Ellis, the first-of-its-kind AI-native opera...

LOS ANGELES--(BUSINESS WIRE)--Kilroy Realty Corporation (NYSE: KRC, the “Company”) announced today that Jeffrey Kuehling will be leaving the Company, effective as of today. In connection with his departure, Eliott Trencher will assume the roles of Chief Financial Officer and Treasurer on an interim basis. The Company has initiated an executive search effort through Russell Reynolds Associates (“RRA”) to identify and appoint a new Chief Financial Officer. Mr. Trencher, who joined the Company in...

WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics (IST), a subsidiary of Innoviva, Inc. (NASDAQ: INVA), announced today that three of the company’s infectious disease therapies, XACDURO® (sulbactam/durlobactam for injection), ZEVTERA® (ceftobiprole medocaril sodium for injection), and NUZOLVENCE® (zoliflodacin) are finalists for the 2026 Prix Galien USA Award in the Best Pharmaceutical Product category. This marks the third consecutive year an Innoviva Specialty Therapeutics prod...

SAN FRANCISCO--(BUSINESS WIRE)--Grove Collaborative Holdings, Inc. (NYSE: GROV) (“Grove” or “the Company”) reports that, on August 7, 2026, it received written notice (the “NYSE Notice”) from the New York Stock Exchange (“NYSE”) of non-compliance with Section 802.01B of the NYSE Listed Company Manual (the “NYSE Manual”), which requires an average global market capitalization of not less than $50 million over a consecutive 30 trading-day period and stockholders’ equity of not less than $50 milli...

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the second quarter ending June 30, 2026 and provided a business update. “While we have regulatory applications under review across the U.S., EU, and U.K., the U.S. represents our nearest-term opportunity,” said Matt Pauls, J.D., M.B.A., Chair and Chief Executive Officer, Savara. “Our focus is on the potential l...